Gilead To Discontinue Phase 3 ENHANCE Study of Magrolimab Plus Azacitidine in Higher-Risk MDS

Magrolimab is a potential first-in-class, anti-CD47 immunotherapy with a clinical development program spanning ten potential indications including ongoing ...

July 24, 2023 | Monday | News
Tillotts Pharma and TVM Capital Form Mage Biologics to Develop Oral Antibody Therapy for Ulcerative Colitis

Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to ensure optimal and local trea...

July 21, 2023 | Friday | News
Eleven Therapeutics Collaborates with Novo Nordisk for Nucleic Acid Therapeutics Discovery

 Through this collaboration, the companies aim to identify novel molecules that promote precise delivery of nucleic acid by leveraging Eleven's innova...

July 18, 2023 | Tuesday | News
DTx Pharma announces acquisition by Novartis

DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON™) platform facilitates extra-hepatic delivery of siRNA therapeutics Acquisition ...

July 18, 2023 | Tuesday | News
Biosynth Expands Capabilities with Acquisition of celares

Expansion of capabilities provides customised bioconjugation solutions for Pharma and IVD industries. Biosynth, a supplier of critical raw materials to th...

July 12, 2023 | Wednesday | News
MaxCyte and Vittoria Biotherapeutics Sign Strategic License for Next-Gen Cellular Therapies

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, de...

July 11, 2023 | Tuesday | News
Thermo Fisher Scientific to Acquire CorEvitas

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced it has entered into a definit...

July 07, 2023 | Friday | News
FDA Grants Orphan Drug Designation to ImPact Biotech's Padeliporfin VTP for Pancreatic Cancer

Designation confers advantages including marketing exclusivity and tax credits  Padeliporfin VTP Phase 1 trial in Pancreatic cancer to start b...

July 06, 2023 | Thursday | News
Paras Biopharma Enhances Protein Expression in Microbial Systems for Cost-effective Biologics Production

The company is pleased to disclose its advancement of up to 12 g or more / L expression of recombinant protein - fully folded / biologically active in ferm...

July 04, 2023 | Tuesday | News
HKSTP and eWTP Arabia Capital Welcome Saudi Delegation to Boost I&T Collaboration

Chief Executive John Lee met with H.E. Eng. Abdullah Al-Swaha, Minister of Communications and Information Technology of Kingdom of Saudi Arabia again fol...

July 04, 2023 | Tuesday | News
Agilent Innovation Again Recognized with Multiple Scientists' Choice Awards

Agilent Technologies Inc. (NYSE: A) has announced the receipt of three 2023 Scientists’ Choice Awards; Best New Spectroscopy Product of 2022, A...

July 04, 2023 | Tuesday | News
Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test

Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has o...

June 29, 2023 | Thursday | News
Eppendorf Award for Young European Investigators 2023 goes to Maurice Michel, Sweden

Maurice Michel, born 1986, receives the 20,000 euro award for his research on artificial functions of DNA repair enzymes for the treatment of Disease. Dr. ...

June 24, 2023 | Saturday | News
Spaulding Clinical Expands Services to Include ADME Clinical Trials

ADME studies are vital components of drug development, providing critical insights into the behavior of drugs within the human body. By measuring the absor...

June 23, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close